Your position:
m.limatoxi.com
>>
EN
>>
Pharmaceutical News
>>
Industry
>>
Icotinib enters into phase Ⅲ trial for lung cancer
>> article
Icotinib enters into phase Ⅲ trial for lung cancer
Editor:bianch Clicks:
0
Date:2009-9-10 14:25:26
Keyword:
Icotinib lung cancer
Healthoo Information:
UserLogin
UserName：
Password：
The non-formal user may read the summary, the formal user can read the whole article。
please at once register the user of Heatlhoo.com
After registration, we will provide the sample reports and the more comprehensive consulting services for you.
UserName
Contact:
Title:
Mr.
Ms.
Password
Repeat password:
Mobile
Email
Verification code:
Company Name
E-mail:xuezhe@healthoo.com
Tel.:86-10-68032463
Our services:
China Im\Ex data service
Service fees of Chinese Vision
Our service items
Online information introduction
Monthly information
Relative Information
KaiMeiNa sales reached 915 MN Yuan in 2015
CFDA warns of online sales of fake ...
Cervical cancer increases among young Chinese...
3 expensive anticancer drugs into medicare&nb...
China encourages private investment for cance...
Lung cancer drug Conmana sold well in&nb...
Sales growth trend of anticancer drugs i...
Cancer on the rise in China
Breast cancer to be top cancer for ...
Conmana (Icotinib) injection launched in Chin...
Address: 13F,NO2 Building, FuXing International, TianHua North Street, Yizhuang, Daxing District, Beijing, P.R. China
Tel:+86-10-68032463
map
